Cytosorbents Non Current Assets Total from 2010 to 2025
| CTSO Stock | USD 1.00 0.02 1.96% |
Non Current Assets Total | First Reported 2005-03-31 | Previous Quarter 31.5 M | Current Value 31.2 M | Quarterly Volatility 10.5 M |
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents Crp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 135 K or Selling General Administrative of 45.7 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.002 or PTB Ratio of 2.01. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
Cytosorbents | Non Current Assets Total |
Latest Cytosorbents Crp's Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of Cytosorbents Crp over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Cytosorbents Crp's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
| Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
| Timeline |
Cytosorbents Non Current Assets Total Regression Statistics
| Arithmetic Mean | 10,910,479 | |
| Geometric Mean | 3,085,222 | |
| Coefficient Of Variation | 120.84 | |
| Mean Deviation | 11,583,120 | |
| Median | 4,483,239 | |
| Standard Deviation | 13,184,720 | |
| Sample Variance | 173.8T | |
| Range | 33.3M | |
| R-Value | 0.89 | |
| Mean Square Error | 38T | |
| R-Squared | 0.80 | |
| Slope | 2,470,953 | |
| Total Sum of Squares | 2607.6T |
Cytosorbents Non Current Assets Total History
About Cytosorbents Crp Financial Statements
Cytosorbents Crp investors utilize fundamental indicators, such as Non Current Assets Total, to predict how Cytosorbents Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Current Assets Total | 31.7 M | 33.3 M |
Check out the analysis of Cytosorbents Crp Correlation against competitors. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.